Stacy J. Kanter's Insider Trades & SAST Disclosures
Stacy J. Kanter's most recent trade in Oppenheimer Holdings Inc - Ordinary Shares - Class A was a trade of 1,500 Class A non-voting common stock done . Disclosure was reported to the exchange on Jan. 30, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Stacy J. Kanter.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oppenheimer Holdings Inc -... | Stacy J. Kanter | Director | Other type of transaction at price $ 0.00 per share. | 30 Jan 2025 | 1,500 | 4,500 (0%) | 0% | - | Class A non-voting common stock | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 45,000 | 108,000 (0%) | 0% | 0 | Common Stock | |
| Oppenheimer Holdings Inc -... | J. Kanter Stacy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 3,000 | 3,000 (0%) | 0% | - | Class A non-voting common stock | |
| Applied Therapeutics Inc | Kanter Stacy J. | Director | Purchase of securities on an exchange or from another person at price $ 2.18 per share. | 01 Dec 2023 | 30,000 | 63,000 (0%) | 0% | 2.2 | 65,367 | Common Stock |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 20,000 | 33,000 (0%) | 0% | 0 | Common Stock | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 20,460 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 20,460 | 20,460 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 10,230 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Purchase of securities on an exchange or from another person at price $ 22.86 per share. | 19 Feb 2021 | 6,500 | 13,000 (0%) | 0% | 22.9 | 148,590 | Common Stock |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 10,230 | 10,230 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges